FDA Approved: IXEMPRA — Supplemental Application (R-Pharm US Operating, LLC)

View source ↗

Summary

The FDA approved a supplemental application for IXEMPRA (ixabepilone) submitted by R-Pharm US Operating, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ixempra (ixabepilone)

Snippet

SUPPL AP for IXEMPRA (IXABEPILONE)